158 related articles for article (PubMed ID: 23602946)
1. The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs.
Alonso P; López-Solà C; Gratacós M; Fullana MA; Segalàs C; Real E; Cardoner N; Soriano-Mas C; Harrison BJ; Estivill X; Menchón JM
J Anxiety Disord; 2013 Apr; 27(3):321-7. PubMed ID: 23602946
[TBL] [Abstract][Full Text] [Related]
2. Neural correlates of obsessive-compulsive related dysfunctional beliefs.
Alonso P; Orbegozo A; Pujol J; López-Solà C; Fullana MÀ; Segalàs C; Real E; Subirà M; Martínez-Zalacaín I; Menchón JM; Harrison BJ; Cardoner N; Soriano-Mas C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():25-32. PubMed ID: 23911440
[TBL] [Abstract][Full Text] [Related]
3. COMT Val158Met polymorphism and executive functions in obsessive-compulsive disorder.
Tükel R; Gürvit H; Öztürk N; Özata B; Ertekin BA; Ertekin E; Baran B; Kalem ŞA; Büyükgök D; Direskeneli GS
J Neuropsychiatry Clin Neurosci; 2013; 25(3):214-21. PubMed ID: 23774999
[TBL] [Abstract][Full Text] [Related]
4. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).
Katerberg H; Lochner C; Cath DC; de Jonge P; Bochdanovits Z; Moolman-Smook JC; Hemmings SM; Carey PD; Stein DJ; Sondervan D; Boer JA; van Balkom AJ; Polman A; Heutink P
Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1050-62. PubMed ID: 19219856
[TBL] [Abstract][Full Text] [Related]
5. Assessment of obsessive beliefs: Comparing individuals with obsessive-compulsive disorder to a medical sample.
Baptista MN; Magna LA; McKay D; Del-Porto JA
J Behav Ther Exp Psychiatry; 2011 Mar; 42(1):1-5. PubMed ID: 21073999
[TBL] [Abstract][Full Text] [Related]
6. An examination of obsessive-compulsive symptoms and dimensions using profile analysis via multidimensional scaling (PAMS).
McKay D; Kim SK; Taylor S; Abramowitz JS; Tolin D; Coles M; Timpano KR; Olatunji B
J Anxiety Disord; 2014 May; 28(4):352-7. PubMed ID: 24786360
[TBL] [Abstract][Full Text] [Related]
7. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder.
Katerberg H; Cath DC; Denys DA; Heutink P; Polman A; van Nieuwerburgh FC; Deforce DL; Bochdanovits Z; van Balkom AJ; den Boer JA
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):167-76. PubMed ID: 19521967
[TBL] [Abstract][Full Text] [Related]
8. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study.
Poyurovsky M; Michaelovsky E; Frisch A; Knoll G; Amir I; Finkel B; Buniak F; Hermesh H; Weizman R
Neurosci Lett; 2005 Nov; 389(1):21-4. PubMed ID: 16043283
[TBL] [Abstract][Full Text] [Related]
9. The neural basis of dysfunctional beliefs in non-medicated patients with obsessive-compulsive disorder.
Nakamae T; Narumoto J; Sakai Y; Nishida S; Yamada K; Fukui K
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):22-5. PubMed ID: 22172533
[TBL] [Abstract][Full Text] [Related]
10. [Washing, checking, and rumination: are the belief domains, obsessions and compulsions specific to OCD subtypes?].
Kaiser B; Bouvard M; Milliery M
Encephale; 2010 Feb; 36(1):54-61. PubMed ID: 20159197
[TBL] [Abstract][Full Text] [Related]
11. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z
J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
[TBL] [Abstract][Full Text] [Related]
13. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
15. Obsessive beliefs in first-degree relatives of patients with OCD: a test of the cognitive vulnerability model.
Rector NA; Cassin SE; Richter MA; Burroughs E
J Anxiety Disord; 2009 Jan; 23(1):145-9. PubMed ID: 18619770
[TBL] [Abstract][Full Text] [Related]
16. Cognitive ability, intraindividual variability, and common genetic variants of catechol-O-methyltransferase and brain-derived neurotrophic factor: a longitudinal study in a population-based sample of older adults.
Das D; Tan X; Bielak AA; Cherbuin N; Easteal S; Anstey KJ
Psychol Aging; 2014 Jun; 29(2):393-403. PubMed ID: 24956006
[TBL] [Abstract][Full Text] [Related]
17. A bifactor model of obsessive beliefs: Specificity in the prediction of obsessive-compulsive disorder symptoms.
Olatunji BO; Ebesutani C; Tolin DF
Psychol Assess; 2019 Feb; 31(2):210-225. PubMed ID: 30307265
[TBL] [Abstract][Full Text] [Related]
18. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.
Karayiorgou M; Sobin C; Blundell ML; Galke BL; Malinova L; Goldberg P; Ott J; Gogos JA
Biol Psychiatry; 1999 May; 45(9):1178-89. PubMed ID: 10331110
[TBL] [Abstract][Full Text] [Related]
19. Association between the Catechol-O-Methyltransferase (COMT) Val¹⁵⁸Met Polymorphism and Alexithymia in Patients with Obsessive-Compulsive Disorder.
Koh MJ; Kang JI; Namkoong K; Lee SY; Kim SJ
Yonsei Med J; 2016 May; 57(3):721-7. PubMed ID: 26996573
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-Methyltransferase Gene Polymorphisms in Specific Obsessive-Compulsive Disorder Patients' Subgroups.
Melo-Felippe FB; de Salles Andrade JB; Giori IG; Vieira-Fonseca T; Fontenelle LF; Kohlrausch FB
J Mol Neurosci; 2016 Jan; 58(1):129-36. PubMed ID: 26687156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
